Cargando...
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries
INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a relatively new class of injectable drugs used in the treatment of type 2 diabetes (T2D). This retrospective database study evaluated real-world treatment patterns of T2D patients initiating GLP-1 RAs in Belgium (BE), France (F...
Guardado en:
| Publicado en: | Diabetes Ther |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5306123/ https://ncbi.nlm.nih.gov/pubmed/28070733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0224-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|